Editing Novo Nordisk A/S (section)

== Corporate Strategy ==
Novo Nordisk's corporate strategy is focused on three main pillars:<ref>https://www.novonordisk.com/about/corporate-governance.html</ref>

* Drive change to defeat diabetes and other serious chronic diseases: Novo Nordisk is committed to finding new and innovative ways to treat diabetes and other chronic diseases. The company is investing heavily in research and development, and is focused on developing new products that can improve the lives of patients.
* Pioneer scientific breakthroughs and expand access to medicines: Novo Nordisk is also committed to pioneering scientific breakthroughs and expanding access to medicines. The company is working to make its products more affordable and accessible to patients around the world.
* Work to prevent, and ultimately cure, these diseases: Novo Nordisk is also committed to working to prevent, and ultimately cure, diabetes and other chronic diseases. The company is investing in research into new prevention strategies, and is working to develop new technologies that can help to cure these diseases.

In order to achieve its corporate strategy, Novo Nordisk is focused on the following key areas:

* Innovation: Novo Nordisk is committed to continuous innovation, and is investing heavily in research and development. The company has a strong track record of innovation, and has launched a number of breakthrough products in recent years.
* Global reach: Novo Nordisk has a global reach, with operations in over 70 countries. This allows the company to reach patients around the world, and to address the growing burden of diabetes and other chronic diseases.
* Sustainability: Novo Nordisk is committed to sustainability, and is working to reduce its environmental impact. The company has set ambitious targets for reducing its carbon emissions, and is working to make its operations more sustainable.

Novo Nordisk is a leading global pharmaceutical company, and its corporate strategy is focused on addressing the growing burden of diabetes and other chronic diseases. The company is committed to innovation, global reach, and sustainability, and is working to make its products more affordable and accessible to patients around the world.